1 Enoxaparin Sodium Market Overview 1.1 Product Overview and Scope of Enoxaparin Sodium 1.2 Enoxaparin Sodium Segment by Type 1.2.1 Global Enoxaparin Sodium Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 20 mg/0.2mL 1.2.3 30 mg/0.3mL 1.2.4 40 mg/0.4mL 1.2.5 60 mg/0.6mL 1.2.6 80 mg/0.8mL 1.2.7 100 mg/1mL 1.2.8 120 mg/0.8mL 1.2.9 150 mg/1mL 1.2.10 300mg/3mL 1.3 Enoxaparin Sodium Segment by Application 1.3.1 Global Enoxaparin Sodium Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Enoxaparin Sodium Market Size Estimates and Forecasts 1.4.1 Global Enoxaparin Sodium Revenue 2017-2028 1.4.2 Global Enoxaparin Sodium Sales 2017-2028 1.4.3 Enoxaparin Sodium Market Size by Region: 2017 Versus 2021 Versus 2028 2 Enoxaparin Sodium Market Competition by Manufacturers 2.1 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2017-2022) 2.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Enoxaparin Sodium Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Enoxaparin Sodium Manufacturing Sites, Area Served, Product Type 2.5 Enoxaparin Sodium Market Competitive Situation and Trends 2.5.1 Enoxaparin Sodium Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Enoxaparin Sodium Players Market Share by Revenue 2.5.3 Global Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Enoxaparin Sodium Retrospective Market Scenario by Region 3.1 Global Enoxaparin Sodium Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Enoxaparin Sodium Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Enoxaparin Sodium Market Facts & Figures by Country 3.3.1 North America Enoxaparin Sodium Sales by Country 3.3.2 North America Enoxaparin Sodium Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Enoxaparin Sodium Market Facts & Figures by Country 3.4.1 Europe Enoxaparin Sodium Sales by Country 3.4.2 Europe Enoxaparin Sodium Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Region 3.5.1 Asia Pacific Enoxaparin Sodium Sales by Region 3.5.2 Asia Pacific Enoxaparin Sodium Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Enoxaparin Sodium Market Facts & Figures by Country 3.6.1 Latin America Enoxaparin Sodium Sales by Country 3.6.2 Latin America Enoxaparin Sodium Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country 3.7.1 Middle East and Africa Enoxaparin Sodium Sales by Country 3.7.2 Middle East and Africa Enoxaparin Sodium Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Enoxaparin Sodium Historic Market Analysis by Type 4.1 Global Enoxaparin Sodium Sales Market Share by Type (2017-2022) 4.2 Global Enoxaparin Sodium Revenue Market Share by Type (2017-2022) 4.3 Global Enoxaparin Sodium Price by Type (2017-2022) 5 Global Enoxaparin Sodium Historic Market Analysis by Application 5.1 Global Enoxaparin Sodium Sales Market Share by Application (2017-2022) 5.2 Global Enoxaparin Sodium Revenue Market Share by Application (2017-2022) 5.3 Global Enoxaparin Sodium Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Sanofi 6.1.1 Sanofi Corporation Information 6.1.2 Sanofi Description and Business Overview 6.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Sanofi Enoxaparin Sodium Product Portfolio 6.1.5 Sanofi Recent Developments/Updates 6.2 Teva 6.2.1 Teva Corporation Information 6.2.2 Teva Description and Business Overview 6.2.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Teva Enoxaparin Sodium Product Portfolio 6.2.5 Teva Recent Developments/Updates 6.3 Techdow (Hepalink) 6.3.1 Techdow (Hepalink) Corporation Information 6.3.2 Techdow (Hepalink) Description and Business Overview 6.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio 6.3.5 Techdow (Hepalink) Recent Developments/Updates 6.4 Fresenius Kabi 6.4.1 Fresenius Kabi Corporation Information 6.4.2 Fresenius Kabi Description and Business Overview 6.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio 6.4.5 Fresenius Kabi Recent Developments/Updates 6.5 Rovi 6.5.1 Rovi Corporation Information 6.5.2 Rovi Description and Business Overview 6.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Rovi Enoxaparin Sodium Product Portfolio 6.5.5 Rovi Recent Developments/Updates 6.6 Amphastar 6.6.1 Amphastar Corporation Information 6.6.2 Amphastar Description and Business Overview 6.6.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Amphastar Enoxaparin Sodium Product Portfolio 6.6.5 Amphastar Recent Developments/Updates 6.7 Nanjing King-friend 6.6.1 Nanjing King-friend Corporation Information 6.6.2 Nanjing King-friend Description and Business Overview 6.6.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio 6.7.5 Nanjing King-friend Recent Developments/Updates 6.8 Sandoz 6.8.1 Sandoz Corporation Information 6.8.2 Sandoz Description and Business Overview 6.8.3 Sandoz Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Sandoz Enoxaparin Sodium Product Portfolio 6.8.5 Sandoz Recent Developments/Updates 6.9 Apotex 6.9.1 Apotex Corporation Information 6.9.2 Apotex Description and Business Overview 6.9.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Apotex Enoxaparin Sodium Product Portfolio 6.9.5 Apotex Recent Developments/Updates 6.10 Hangzhou Jiuyuan Gene Engineering 6.10.1 Hangzhou Jiuyuan Gene Engineering Corporation Information 6.10.2 Hangzhou Jiuyuan Gene Engineering Description and Business Overview 6.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio 6.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates 6.11 Cipla 6.11.1 Cipla Corporation Information 6.11.2 Cipla Enoxaparin Sodium Description and Business Overview 6.11.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Cipla Enoxaparin Sodium Product Portfolio 6.11.5 Cipla Recent Developments/Updates 6.12 Taj Pharma 6.12.1 Taj Pharma Corporation Information 6.12.2 Taj Pharma Enoxaparin Sodium Description and Business Overview 6.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio 6.12.5 Taj Pharma Recent Developments/Updates 6.13 Chengdu Baiyu Pharmaceutical 6.13.1 Chengdu Baiyu Pharmaceutical Corporation Information 6.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Description and Business Overview 6.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio 6.13.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates 6.14 Suzhou Erye Pharmaceutical 6.14.1 Suzhou Erye Pharmaceutical Corporation Information 6.14.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Description and Business Overview 6.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio 6.14.5 Suzhou Erye Pharmaceutical Recent Developments/Updates 6.15 Changzhou Qianhong Bio-pharma 6.15.1 Changzhou Qianhong Bio-pharma Corporation Information 6.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Description and Business Overview 6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio 6.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates 6.16 Hebei Changshan Biochemical Pharmaceutical 6.16.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information 6.16.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Description and Business Overview 6.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio 6.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates 6.17 Beijing SL Pharmaceutical 6.17.1 Beijing SL Pharmaceutical Corporation Information 6.17.2 Beijing SL Pharmaceutical Enoxaparin Sodium Description and Business Overview 6.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio 6.17.5 Beijing SL Pharmaceutical Recent Developments/Updates 6.18 Huadong Medicine 6.18.1 Huadong Medicine Corporation Information 6.18.2 Huadong Medicine Enoxaparin Sodium Description and Business Overview 6.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio 6.18.5 Huadong Medicine Recent Developments/Updates 6.19 Bharat Serums 6.19.1 Bharat Serums Corporation Information 6.19.2 Bharat Serums Enoxaparin Sodium Description and Business Overview 6.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio 6.19.5 Bharat Serums Recent Developments/Updates 6.20 INTAS 6.20.1 INTAS Corporation Information 6.20.2 INTAS Enoxaparin Sodium Description and Business Overview 6.20.3 INTAS Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.20.4 INTAS Enoxaparin Sodium Product Portfolio 6.20.5 INTAS Recent Developments/Updates 6.21 LUPIN 6.21.1 LUPIN Corporation Information 6.21.2 LUPIN Enoxaparin Sodium Description and Business Overview 6.21.3 LUPIN Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.21.4 LUPIN Enoxaparin Sodium Product Portfolio 6.21.5 LUPIN Recent Developments/Updates 6.22 Troikaa Pharmaceuticals 6.22.1 Troikaa Pharmaceuticals Corporation Information 6.22.2 Troikaa Pharmaceuticals Enoxaparin Sodium Description and Business Overview 6.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio 6.22.5 Troikaa Pharmaceuticals Recent Developments/Updates 6.23 Aristopharma 6.23.1 Aristopharma Corporation Information 6.23.2 Aristopharma Enoxaparin Sodium Description and Business Overview 6.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.23.4 Aristopharma Enoxaparin Sodium Product Portfolio 6.23.5 Aristopharma Recent Developments/Updates 6.24 Fosun Pharma 6.24.1 Fosun Pharma Corporation Information 6.24.2 Fosun Pharma Enoxaparin Sodium Description and Business Overview 6.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio 6.24.5 Fosun Pharma Recent Developments/Updates 6.25 SciencePharma 6.25.1 SciencePharma Corporation Information 6.25.2 SciencePharma Enoxaparin Sodium Description and Business Overview 6.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.25.4 SciencePharma Enoxaparin Sodium Product Portfolio 6.25.5 SciencePharma Recent Developments/Updates 6.26 PISA 6.26.1 PISA Corporation Information 6.26.2 PISA Enoxaparin Sodium Description and Business Overview 6.26.3 PISA Enoxaparin Sodium Sales, Revenue and Gross Margin (2017-2022) 6.26.4 PISA Enoxaparin Sodium Product Portfolio 6.26.5 PISA Recent Developments/Updates 7 Enoxaparin Sodium Manufacturing Cost Analysis 7.1 Enoxaparin Sodium Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Enoxaparin Sodium 7.4 Enoxaparin Sodium Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Enoxaparin Sodium Distributors List 8.3 Enoxaparin Sodium Customers 9 Enoxaparin Sodium Market Dynamics 9.1 Enoxaparin Sodium Industry Trends 9.2 Enoxaparin Sodium Market Drivers 9.3 Enoxaparin Sodium Market Challenges 9.4 Enoxaparin Sodium Market Restraints 10 Global Market Forecast 10.1 Enoxaparin Sodium Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Enoxaparin Sodium by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Enoxaparin Sodium by Type (2023-2028) 10.2 Enoxaparin Sodium Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Enoxaparin Sodium by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Enoxaparin Sodium by Application (2023-2028) 10.3 Enoxaparin Sodium Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Enoxaparin Sodium by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Enoxaparin Sodium by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Enoxaparin Sodium Sales Growth Rate Comparison by Type (2022-2028) & (M Units) & (US$ Million) Table 2. Global Enoxaparin Sodium Sales Growth Rate Comparison by Application (2022-2028) & (M Units) & (US$ Million) Table 3. Global Enoxaparin Sodium Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Enoxaparin Sodium Market Competitive Situation by Manufacturers in 2021 Table 5. Global Enoxaparin Sodium Sales (M Units) of Key Manufacturers (2017-2022) Table 6. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2017-2022) Table 7. Global Enoxaparin Sodium Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Enoxaparin Sodium Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Enoxaparin Sodium Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Enoxaparin Sodium Manufacturing Sites and Area Served Table 11. Manufacturers Enoxaparin Sodium Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enoxaparin Sodium as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Enoxaparin Sodium Sales by Region (2017-2022) & (M Units) Table 16. Global Enoxaparin Sodium Sales Market Share by Region (2017-2022) Table 17. Global Enoxaparin Sodium Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Enoxaparin Sodium Revenue Market Share by Region (2017-2022) Table 19. North America Enoxaparin Sodium Sales by Country (2017-2022) & (M Units) Table 20. North America Enoxaparin Sodium Sales Market Share by Country (2017-2022) Table 21. North America Enoxaparin Sodium Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Enoxaparin Sodium Revenue Market Share by Country (2017-2022) Table 23. Europe Enoxaparin Sodium Sales by Country (2017-2022) & (M Units) Table 24. Europe Enoxaparin Sodium Sales Market Share by Country (2017-2022) Table 25. Europe Enoxaparin Sodium Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Enoxaparin Sodium Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Enoxaparin Sodium Sales by Region (2017-2022) & (M Units) Table 28. Asia Pacific Enoxaparin Sodium Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Enoxaparin Sodium Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Enoxaparin Sodium Revenue Market Share by Region (2017-2022) Table 31. Latin America Enoxaparin Sodium Sales by Country (2017-2022) & (M Units) Table 32. Latin America Enoxaparin Sodium Sales Market Share by Country (2017-2022) Table 33. Latin America Enoxaparin Sodium Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Enoxaparin Sodium Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Enoxaparin Sodium Sales by Country (2017-2022) & (M Units) Table 36. Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Enoxaparin Sodium Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Enoxaparin Sodium Revenue Market Share by Country (2017-2022) Table 39. Global Enoxaparin Sodium Sales by Type (2017-2022) & (M Units) Table 40. Global Enoxaparin Sodium Sales Market Share by Type (2017-2022) Table 41. Global Enoxaparin Sodium Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Enoxaparin Sodium Revenue Share by Type (2017-2022) Table 43. Global Enoxaparin Sodium Price by Type (2017-2022) & (US$/Unit) Table 44. Global Enoxaparin Sodium Sales (M Units) by Application (2017-2022) Table 45. Global Enoxaparin Sodium Sales Market Share by Application (2017-2022) Table 46. Global Enoxaparin Sodium Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Enoxaparin Sodium Revenue Share by Application (2017-2022) Table 48. Global Enoxaparin Sodium Price by Application (2017-2022) & (US$/Unit) Table 49. Sanofi Corporation Information Table 50. Sanofi Description and Business Overview Table 51. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Sanofi Enoxaparin Sodium Product Table 53. Sanofi Recent Developments/Updates Table 54. Teva Corporation Information Table 55. Teva Description and Business Overview Table 56. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Teva Enoxaparin Sodium Product Table 58. Teva Recent Developments/Updates Table 59. Techdow (Hepalink) Corporation Information Table 60. Techdow (Hepalink) Description and Business Overview Table 61. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Techdow (Hepalink) Enoxaparin Sodium Product Table 63. Techdow (Hepalink) Recent Developments/Updates Table 64. Fresenius Kabi Corporation Information Table 65. Fresenius Kabi Description and Business Overview Table 66. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Fresenius Kabi Enoxaparin Sodium Product Table 68. Fresenius Kabi Recent Developments/Updates Table 69. Rovi Corporation Information Table 70. Rovi Description and Business Overview Table 71. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Rovi Enoxaparin Sodium Product Table 73. Rovi Recent Developments/Updates Table 74. Amphastar Corporation Information Table 75. Amphastar Description and Business Overview Table 76. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Amphastar Enoxaparin Sodium Product Table 78. Amphastar Recent Developments/Updates Table 79. Nanjing King-friend Corporation Information Table 80. Nanjing King-friend Description and Business Overview Table 81. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Nanjing King-friend Enoxaparin Sodium Product Table 83. Nanjing King-friend Recent Developments/Updates Table 84. Sandoz Corporation Information Table 85. Sandoz Description and Business Overview Table 86. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Sandoz Enoxaparin Sodium Product Table 88. Sandoz Recent Developments/Updates Table 89. Apotex Corporation Information Table 90. Apotex Description and Business Overview Table 91. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Apotex Enoxaparin Sodium Product Table 93. Apotex Recent Developments/Updates Table 94. Hangzhou Jiuyuan Gene Engineering Corporation Information Table 95. Hangzhou Jiuyuan Gene Engineering Description and Business Overview Table 96. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Table 98. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates Table 99. Cipla Corporation Information Table 100. Cipla Description and Business Overview Table 101. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Cipla Enoxaparin Sodium Product Table 103. Cipla Recent Developments/Updates Table 104. Taj Pharma Corporation Information Table 105. Taj Pharma Description and Business Overview Table 106. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Taj Pharma Enoxaparin Sodium Product Table 108. Taj Pharma Recent Developments/Updates Table 109. Chengdu Baiyu Pharmaceutical Corporation Information Table 110. Chengdu Baiyu Pharmaceutical Description and Business Overview Table 111. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 112. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Table 113. Chengdu Baiyu Pharmaceutical Recent Developments/Updates Table 114. Suzhou Erye Pharmaceutical Corporation Information Table 115. Suzhou Erye Pharmaceutical Description and Business Overview Table 116. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 117. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Table 118. Suzhou Erye Pharmaceutical Recent Developments/Updates Table 119. Changzhou Qianhong Bio-pharma Corporation Information Table 120. Changzhou Qianhong Bio-pharma Description and Business Overview Table 121. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 122. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Table 123. Changzhou Qianhong Bio-pharma Recent Developments/Updates Table 124. Hebei Changshan Biochemical Pharmaceutical Corporation Information Table 125. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview Table 126. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 127. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Table 128. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates Table 129. Beijing SL Pharmaceutical Corporation Information Table 130. Beijing SL Pharmaceutical Description and Business Overview Table 131. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 132. Beijing SL Pharmaceutical Enoxaparin Sodium Product Table 133. Beijing SL Pharmaceutical Recent Developments/Updates Table 134. Huadong Medicine Corporation Information Table 135. Huadong Medicine Description and Business Overview Table 136. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 137. Huadong Medicine Enoxaparin Sodium Product Table 138. Huadong Medicine Recent Developments/Updates Table 139. Bharat Serums Corporation Information Table 140. Bharat Serums Description and Business Overview Table 141. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 142. Bharat Serums Enoxaparin Sodium Product Table 143. Bharat Serums Recent Developments/Updates Table 144. INTAS Corporation Information Table 145. INTAS Description and Business Overview Table 146. INTAS Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 147. INTAS Enoxaparin Sodium Product Table 148. INTAS Recent Developments/Updates Table 149. LUPIN Corporation Information Table 150. LUPIN Description and Business Overview Table 151. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 152. LUPIN Enoxaparin Sodium Product Table 153. LUPIN Recent Developments/Updates Table 154. Troikaa Pharmaceuticals Corporation Information Table 155. Troikaa Pharmaceuticals Description and Business Overview Table 156. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 157. Troikaa Pharmaceuticals Enoxaparin Sodium Product Table 158. Troikaa Pharmaceuticals Recent Developments/Updates Table 159. Aristopharma Corporation Information Table 160. Aristopharma Description and Business Overview Table 161. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 162. Aristopharma Enoxaparin Sodium Product Table 163. Aristopharma Recent Developments/Updates Table 164. Fosun Pharma Corporation Information Table 165. Fosun Pharma Description and Business Overview Table 166. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 167. Fosun Pharma Enoxaparin Sodium Product Table 168. Fosun Pharma Recent Developments/Updates Table 169. SciencePharma Corporation Information Table 170. SciencePharma Description and Business Overview Table 171. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 172. SciencePharma Enoxaparin Sodium Product Table 173. SciencePharma Recent Developments/Updates Table 174. PISA Corporation Information Table 175. PISA Description and Business Overview Table 176. PISA Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 177. PISA Enoxaparin Sodium Product Table 178. PISA Recent Developments/Updates Table 179. Production Base and Market Concentration Rate of Raw Material Table 180. Key Suppliers of Raw Materials Table 181. Enoxaparin Sodium Distributors List Table 182. Enoxaparin Sodium Customers List Table 183. Enoxaparin Sodium Market Trends Table 184. Enoxaparin Sodium Market Drivers Table 185. Enoxaparin Sodium Market Challenges Table 186. Enoxaparin Sodium Market Restraints Table 187. Global Enoxaparin Sodium Sales Forecast by Type (2023-2028) & (M Units) Table 188. Global Enoxaparin Sodium Sales Market Share Forecast by Type (2023-2028) Table 189. Global Enoxaparin Sodium Revenue Forecast by Type (2023-2028) & (US$ Million) Table 190. Global Enoxaparin Sodium Revenue Market Share Forecast by Type (2023-2028) Table 191. Global Enoxaparin Sodium Sales Forecast by Application (2023-2028) & (M Units) Table 192. Global Enoxaparin Sodium Sales Market Share Forecast by Application (2023-2028) Table 193. Global Enoxaparin Sodium Revenue Forecast by Application (2023-2028) & (US$ Million) Table 194. Global Enoxaparin Sodium Revenue Market Share Forecast by Application (2023-2028) Table 195. Global Enoxaparin Sodium Sales Forecast by Region (2023-2028) & (M Units) Table 196. Global Enoxaparin Sodium Sales Market Share Forecast by Region (2023-2028) Table 197. Global Enoxaparin Sodium Revenue Forecast by Region (2023-2028) & (US$ Million) Table 198. Global Enoxaparin Sodium Revenue Market Share Forecast by Region (2023-2028) Table 199. Research Programs/Design for This Report Table 200. Key Data Information from Secondary Sources Table 201. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Enoxaparin Sodium Figure 2. Global Enoxaparin Sodium Market Share by Type in 2021 & 2028 Figure 3. 20 mg/0.2mL Product Picture Figure 4. 30 mg/0.3mL Product Picture Figure 5. 40 mg/0.4mL Product Picture Figure 6. 60 mg/0.6mL Product Picture Figure 7. 80 mg/0.8mL Product Picture Figure 8. 100 mg/1mL Product Picture Figure 9. 120 mg/0.8mL Product Picture Figure 10. 150 mg/1mL Product Picture Figure 11. 300mg/3mL Product Picture Figure 12. Global Enoxaparin Sodium Market Share by Application in 2021 & 2028 Figure 13. Hospital Figure 14. Clinic Figure 15. Others Figure 16. Global Enoxaparin Sodium Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Enoxaparin Sodium Market Size (2017-2028) & (US$ Million) Figure 18. Global Enoxaparin Sodium Sales (2017-2028) & (M Units) Figure 19. Enoxaparin Sodium Sales Share by Manufacturers in 2021 Figure 20. Global Enoxaparin Sodium Revenue Share by Manufacturers in 2021 Figure 21. The Global 5 and 10 Largest Enoxaparin Sodium Players: Market Share by Revenue in 2021 Figure 22. Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 23. Global Enoxaparin Sodium Sales Market Share by Region (2017-2022) Figure 24. Global Enoxaparin Sodium Sales Market Share by Region in 2021 Figure 25. Global Enoxaparin Sodium Revenue Market Share by Region (2017-2022) Figure 26. Global Enoxaparin Sodium Revenue Market Share by Region in 2021 Figure 27. United States Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Canada Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Germany Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. France Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. U.K. Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Italy Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Russia Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. China Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Japan Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. South Korea Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. India Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Australia Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. China Taiwan Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Indonesia Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Thailand Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Malaysia Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Mexico Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Brazil Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Argentina Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Turkey Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Saudi Arabia Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 48. UAE Enoxaparin Sodium Revenue Growth Rate (2017-2022) & (US$ Million) Figure 49. Sales Market Share of Enoxaparin Sodium by Type (2017-2022) Figure 50. Manufacturing Cost Structure of Enoxaparin Sodium Figure 51. Manufacturing Process Analysis of Enoxaparin Sodium Figure 52. Enoxaparin Sodium Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Sanofi Teva Techdow (Hepalink) Fresenius Kabi Rovi Amphastar Nanjing King-friend Sandoz Apotex Hangzhou Jiuyuan Gene Engineering Cipla Taj Pharma Chengdu Baiyu Pharmaceutical Suzhou Erye Pharmaceutical Changzhou Qianhong Bio-pharma Hebei Changshan Biochemical Pharmaceutical Beijing SL Pharmaceutical Huadong Medicine Bharat Serums INTAS LUPIN Troikaa Pharmaceuticals Aristopharma Fosun Pharma SciencePharma PISA